False-negative 18F-PSMA-1007 PET/CT in metastatic prostate cancer related to high physiologic liver uptake

被引:6
|
作者
Hartrampf, Philipp E. [1 ]
Seitz, Anna Katharina [2 ]
Krebs, Markus [2 ,3 ]
Buck, Andreas K. [1 ]
Lapa, Constantin [1 ,4 ]
机构
[1] Univ Hosp Wurzburg, Dept Nucl Med, Wurzburg, Germany
[2] Univ Hosp Wurzburg, Dept Urol & Paediat Urol, Wurzburg, Germany
[3] Univ Hosp Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany
[4] Univ Hosp Augsburg, Dept Nucl Med, Augsburg, Germany
关键词
Liver; -; Urology;
D O I
10.1007/s00259-019-04645-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
[No abstract available]
引用
收藏
页码:2044 / 2046
页数:3
相关论文
共 50 条
  • [1] False-negative 18F-PSMA-1007 PET/CT in metastatic prostate cancer related to high physiologic liver uptake
    Philipp E. Hartrampf
    Anna Katharina Seitz
    Markus Krebs
    Andreas K. Buck
    Constantin Lapa
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 2044 - 2046
  • [2] Equivocal Radiotracer Uptake on 18F-PSMA-1007 PET/CT in Patients with Prostate Cancer
    Spurr, M.
    Kimura, M.
    Kulshresthra, R.
    Kabala, J.
    Challapalli, A.
    Sakthithasan, M.
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 41 - 42
  • [3] Non-prostate uptake on 18F-PSMA-1007 PET/CT: a case of myeloma
    Veerasuri, Sowmya
    Redman, Stewart
    Graham, Richard
    Meehan, Chris
    Little, David
    BJR CASE REPORTS, 2021, 7 (02):
  • [4] Skeletal 18F-PSMA-1007 uptake in prostate cancer patients
    Janssen, Jorinde
    Noordzij, Walter
    Velleman, Ton
    de Jong, Igle Jan
    Langendijk, Johannes A.
    Verzijlbergen, J. Fred
    Stormezand, Gilles N.
    Aluwini, Shafak
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [5] The value of 18F-PSMA-1007 PET/CT in identifying non-metastatic high-risk prostate cancer
    Jun-jie Hong
    Bo-le Liu
    Zhi-qiang Wang
    Kun Tang
    Xiao-wei Ji
    Wei-wei Yin
    Jie Lin
    Xiang-wu Zheng
    EJNMMI Research, 10
  • [6] The value of 18F-PSMA-1007 PET/CT in identifying non-metastatic high-risk prostate cancer
    Hong, Jun-jie
    Liu, Bo-le
    Wang, Zhi-qiang
    Tang, Kun
    Ji, Xiao-wei
    Yin, Wei-wei
    Lin, Jie
    Zheng, Xiang-wu
    EJNMMI RESEARCH, 2020, 10 (01)
  • [7] Incidental Finding of Colon Carcinoma Related to High Uptake in 18F-PSMA-1007 PET
    Arcay, Ayca
    Eiber, Matthias
    Langbein, Thomas
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (07) : 561 - 562
  • [8] Comparison of the 18F-PSMA-1007 and 18F-FAPI-42 PET/ CT in the evaluation of prostate cancer and correlation between PSMA and FAPI uptake
    Mu, X.
    Li, M.
    Fu, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S536 - S536
  • [9] COVID-19-Related Lung Parenchymal Uptake on 18F-PSMA-1007 PET/CT
    Nawwar, Ayah A.
    Searle, Julie
    Green, Jes S.
    Lyburn, Iain D.
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (12) : 1016 - 1017
  • [10] Increased Uptake of 18F-PSMA-1007 in Corpus Luteum Demonstrated by PET/CT
    Geysen, Astrid
    Goffin, Karolien
    Van Weehaeghe, Donatienne
    Van Laere, Koen
    Deroose, Christophe M.
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (03) : E331 - E332